Search research articles
Contact Us
Filters
Showing results (51-60 of 132) with videos related to
Page
of 14
Sort By:
Digestive Diseases and Sciences
|
September 1, 1990
Neurohumoral control of gallbladder motility in healthy subjects and diabetic patients with or without autonomic neuropathy
S Fiorucci, R Bosso, L Scionti, et al.
Clinics and Research in Hepatology and Gastroenterology
|
June 19, 2018
Cameron lesions: A still overlooked diagnosis. Case report and systematic review of literature
A Zullo, R Manta, V De Francesco, et al.
Alimentary Pharmacology & Therapeutics
|
December 1, 2007
Is interleukin-1 genotyping useful for the clinical management of patients with atrophic body gastritis?
E Lahner, V D Corleto, G D'Ambra, et al.
Histopathology
|
October 1, 1992
Focal oxyntic gland atrophy with endocrine cell hyperplasia in Zollinger-Ellison syndrome during omeprazole treatment
P Caruana, C Azzoni, A Bertelé, et al.
Clinics and Research in Hepatology and Gastroenterology
|
December 24, 2018
Erratum to "Cameron lesions: A still overlooked diagnosis. Case report and systematic review of literature" [Clin. Res. Hepatol. Gastroenterol. 42 (2018) 604-609]
A Zullo, R Manta, V De Francesco, et al.
Helicobacter
|
October 31, 2001
Two-thirds of atrophic body gastritis patients have evidence of Helicobacter pylori infection
B Annibale, R Negrini, P Caruana, et al.
Gut
|
March 13, 2003
Concomitant alterations in intragastric pH and ascorbic acid concentration in patients with Helicobacter pylori gastritis and associated iron deficiency anaemia
B Annibale, G Capurso, E Lahner, et al.
Alimentary Pharmacology & Therapeutics
|
February 24, 2010
Risk factors for progression to gastric neoplastic lesions in patients with atrophic gastritis
L Vannella, E Lahner, J Osborn, et al.
Alimentary Pharmacology & Therapeutics
|
July 15, 1998
Omeprazole 20 or 40 mg daily for healing gastroduodenal ulcers in patients receiving non-steroidal anti-inflammatory drugs
G Massimo Claar, S Monaco, C Del Veccho Blanco, et al.
Alimentary Pharmacology & Therapeutics
|
September 25, 2002
The long-term effects of cure of Helicobacter pylori infection on patients with atrophic body gastritis
B Annibale, E Di Giulio, P Caruana, et al.
Page
of 14
Search research articles
Search
Showing results (51-60 of 132) with videos related to
Sort By:
Page
of 14
Digestive Diseases and Sciences
|
September 1, 1990
Neurohumoral control of gallbladder motility in healthy subjects and diabetic patients with or without autonomic neuropathy
S Fiorucci, R Bosso, L Scionti, et al.
Clinics and Research in Hepatology and Gastroenterology
|
June 19, 2018
Cameron lesions: A still overlooked diagnosis. Case report and systematic review of literature
A Zullo, R Manta, V De Francesco, et al.
Alimentary Pharmacology & Therapeutics
|
December 1, 2007
Is interleukin-1 genotyping useful for the clinical management of patients with atrophic body gastritis?
E Lahner, V D Corleto, G D'Ambra, et al.
Histopathology
|
October 1, 1992
Focal oxyntic gland atrophy with endocrine cell hyperplasia in Zollinger-Ellison syndrome during omeprazole treatment
P Caruana, C Azzoni, A Bertelé, et al.
Clinics and Research in Hepatology and Gastroenterology
|
December 24, 2018
Erratum to "Cameron lesions: A still overlooked diagnosis. Case report and systematic review of literature" [Clin. Res. Hepatol. Gastroenterol. 42 (2018) 604-609]
A Zullo, R Manta, V De Francesco, et al.
Helicobacter
|
October 31, 2001
Two-thirds of atrophic body gastritis patients have evidence of Helicobacter pylori infection
B Annibale, R Negrini, P Caruana, et al.
Gut
|
March 13, 2003
Concomitant alterations in intragastric pH and ascorbic acid concentration in patients with Helicobacter pylori gastritis and associated iron deficiency anaemia
B Annibale, G Capurso, E Lahner, et al.
Alimentary Pharmacology & Therapeutics
|
February 24, 2010
Risk factors for progression to gastric neoplastic lesions in patients with atrophic gastritis
L Vannella, E Lahner, J Osborn, et al.
Alimentary Pharmacology & Therapeutics
|
July 15, 1998
Omeprazole 20 or 40 mg daily for healing gastroduodenal ulcers in patients receiving non-steroidal anti-inflammatory drugs
G Massimo Claar, S Monaco, C Del Veccho Blanco, et al.
Alimentary Pharmacology & Therapeutics
|
September 25, 2002
The long-term effects of cure of Helicobacter pylori infection on patients with atrophic body gastritis
B Annibale, E Di Giulio, P Caruana, et al.
Page
of 14